Skip to main content
Premium Trial:

Request an Annual Quote

Markman Ruling in Third Wave/Digene HPV Suit Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, July 27.
1. Judge's Markman Ruling Sides With Third Wave in Digene HPV IP Row (from July 25)
2. California Court Tosses Gen-Probe Complaint Against Digene; Arbitration on HPVs Open (from July 23)
3. Illumina to Co-develop SNP Chip for Vascular Disease with NHLBI, Penn, and Broad (from July 23)
4. PerkinElmer's LAS Head to Replace Summe as CEO in February; Q2 Revenue, Profits Rise (from July 27)
5. ABI Accelerates Next-Gen Sequencer Launch; Fiscal Q4 Sales Rise 7 Percent (from July 25)
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more